Background/aims-Recent studies have demonstrated the existence of two oestrogen receptor subtypes (OR ) and (OR ) with significant diVerences of expression among organs. Since important pathologies of human eye could be linked to hormonal status, the expression of OR in ocular posterior segment was sought. Methods-Immunohistochemical localisation of OR and OR protein and detection of OR mRNAs by reverse transcription-polymerase chain reaction (RT-PCR) were performed in macular and extramacular regions of the retina and in the choroid on male and female donors eyes. Results-OR protein was localised in the ganglion cell layer and in the choroid. At the transcriptional level, mRNA for OR and for OR were both present. Local differences in the expression level were observed, however, suggesting the possibility of variation in the ratio of OR v OR . Conclusions-The coexistence of two oestrogen receptor subtypes in the human ocular posterior segment raises acute questions about their potential physiological role, but oVers a perspective for preferential targeting of a specific receptor subtype. (Br J Ophthalmol 2001;85:877-882) Oestrogens are steroid hormones traditionally connected with either reproductive system or with bone tissue and cardiovascular system. Their receptors are members of the nuclear receptor superfamily (including among others, receptors for steroids, vitamin D, and retinoic acid) and they mediate most of the known eVects of oestrogens. These intracellular proteins function as ligand activated transcription factors regulating gene transcription.
Oestrogens are steroid hormones traditionally connected with either reproductive system or with bone tissue and cardiovascular system. Their receptors are members of the nuclear receptor superfamily (including among others, receptors for steroids, vitamin D, and retinoic acid) and they mediate most of the known eVects of oestrogens. These intracellular proteins function as ligand activated transcription factors regulating gene transcription.
A new type of oestrogen receptor, OR has recently been cloned 1 and subsequently its mRNA was found in various organs of male and in diVerent areas of the brain, while OR is found mainly in most female organs. The finding of a second receptor having diVerent tissue distribution and molecular characteristics is obviously raising a question about the interpretation of oestrogens actions in diVerent organs.
The roles of oestrogens in ophthalmic pathology have been mainly evaluated in the anterior segment. Epidemiological and experimental data suggest a protective eVect of oestrogens in age related cataractogenesis. [2] [3] [4] Tear function is influenced by sex hormones, and the onset of dry eye is very common during the menopause. 5 The situation in the retina is more controversial. DiVerent epidemiological studies reported a protective eVect of oestrogen replacement therapy on the development of neovascular age related macular degeneration (AMD) 6 7 while others failed to demonstrate a significant sex diVerence in the frequency of the disease. 8 The reasons for these discordant findings are unknown, but could partly be explained by the considerable diVerences among clinically used oestrogens for their binding aYnities on their receptor subtypes. 9 Kobayashi et al convincingly demonstrated the presence of an oestrogen receptor in the rat and bovine retina, without diVerentiating OR and OR . 10 In the human eye, a recent report suggested the presence of OR in the young female retina.
11
As the retina obviously shares common biological features with the brain, we hypothesised that OR could also be expressed in the retina and/or in the choroid. We report here that the type oestrogen receptor is present in human male and female ocular posterior segments, with some regional diVerences in the level of mRNA expression.
Materials and methods

TISSUE COLLECTION
Human male and female donor eyes (eight males and five females) with a limited postmortem enucleation time (1-15 hours) were collected from the Cornea Bank, University of Liège, Belgium. Mean age was 65 years (range 46-82). After removal of the anterior segment structures, 5 mm diameter punches were made in the macular region and in the peripheral retina. Neural retina was then separated from the retinal pigment epithelium and from the choroid (RPE-choroid complex) and tissues were stored at −80°C. Alternatively, posterior segments were fixed in 4% formalin, dehydrated, and embedded in paraYn.
The mean blood testosterone level in males (measured post mortem by radioimmunoassay, Immunotech) was 0.84 µg/l (range 0.11-2.38) and the mean oestrogen level (Immunotech) in females was 148 ng/l (range 32-303).
IMMUNOCYTOCHEMICAL LOCALISATION OF OR
Frozen sections of 5 µm were fixed 5 minutes in acetone at room temperature, air dried, and covered for 1 hour with 3% normal goat serum. Then, rabbit anti-human oestrogen or receptor (Santa Cruz Biotechnology, CA, USA) diluted 1/25 was applied for 1 hour, sections were rinsed in TRIS/HCl pH 7.4 saline, and covered with one drop of EnVision (Dako, ready to use goat anti-rabbit peroxidase conjugated antibody) for 30 minutes. After rinsing in TRIS/ HCl, one drop of AEC+ (Dako, 3-amino-9-ethylcarbazole) was added. Sections were washed in water, counterstained for 1 minute in haematoxylin, and mounted in Aquamount. DeparaYnised sections were similarly treated excepting for a preliminary microwave step (350 W, four times for 5 minutes in 10 mM sodium citrate buVer, pH 6.0) to unmask antigenic sites. Negative controls were obtained by omitting the
Figure 1 Immunolocalisation of OR (A, D, G) and OR (B, E, H) and negative controls (C, F, I) on paraYn sections of ocular posterior segment at low magnification (×100, A, B, C) or higher magnification (×400) focused either on ganglion cell layer (D, E, F), on the choroid-RPE complex (G, H, I), or selectively on the RPE (J). Note the staining of OR (arrows) in all nuclear layers (A) and the concentration of OR (arrows) in ganglion cell layer (E) and in choroidal structures (H). Ch = choroid; ONL = outer nuclear layer; INL = inner nuclear layer; GCL = ganglion cell layer.
primary antibody, while for positive controls, uterine tissue known to express oestrogen was used (data not shown).
WESTERN BLOT ANALYSIS
Analyses of OR and OR protein expression were performed from 5 mm punches made in the macular region, from testis and HT1080.
Protein extracts were prepared from the cell pellet in RIPA buVer (50 mM TRIS (pH 7.4), 150 mM NaCl, 1% Igepal (v/v), 1% sodium deoxycholate (w/v), 5 mM iodoacetamide, 0.1% SDS (w/v)) containing protease inhibitors (1 mM phenylmethylsulphonyl fluoride, 10 µg/ml leupeptin and 10 µg/ml aprotinin).
For HT1080, total extracts were performed by scraping, in RIPA buVer. Protein concentration was determined with the DC protein assay (BioRad, Richmond, CA, USA).
Samples (20 µg for OR-and ORanalyses) were mixed with 1/5 sample buVer (0.31 M TRIS (pH 6.8), 10% SDS (w/v), 25% glycerol ( v/v), 12.5% mercaptoethanol (v/v), and 0.125% bromophenol blue (w/v)) and boiled for 5 minutes. They were then separated on 7.5% and 12% SDS-PAGE gels for OR and OR analyses respectively and transferred to a PVDF filter (NEN, Boston, MA, USA). The membranes were then blocked with 5% milk (w/v), 0.1% Tween 20 (w/v) in phosphate buVered saline (PBS) for 2 hours before exposure to the primary antibody overnight at 4°C: rabbit anti-human oestrogen or receptor (Santa Cruz Biotechnology, CA, USA). The filters were then incubated either with a horseradish peroxidase conjugated swine anti-rabbit or goat anti-mouse antibody (Dako). Signals were detected with an enhanced chemiluminescence (ECL) kit (NEN, Boston, MA, USA).
DETECTION OF OR AND OR BY RT-PCR
Total RNA from 5 mm punches were extracted using RNeasyMini Kit (Qiagen) as described by the manufacturer. 28S rRNA, OR and OR mRNA were measured in 10 ng aliquots of total RNA using the GeneAmp Thermostable rTth reverse transcriptase RNA-PCR kit 5'-CTCTTTGAACCTGGACCA GTA-3' for OR mRNA, 13 and sense: 5'-GTTCACCCACTAATAGGGAACGTGA-3' and reverse: 5'-GGATTCTGACTTAGAG GCGTTCAGT-3' for 28S rRNA 14 ). Reverse transcription was performed at 70°C for 15 minutes, followed by 2 minutes' incubation at 95°C for denaturation of RNA-DNA heteroduplexes. Amplification started by 15 seconds at 94°C, 20 seconds at 58°C, and 15 seconds at 72°C (35 cycles for OR and OR and 19 cycles for 28S) and terminated by 2 minutes at 72°C. RT-PCR products were resolved on 10% acrylamide gels and analysed using a Fluor-S MultiImager (BioRad) after staining with Gelstar dye (FMC BioProducts).
Results
OR IMMUNOLOCALISATION ON POSTERIOR SEGMENT SECTIONS
Cytoplasmic and nuclear staining with the antioestrogen receptor antibody were mainly observed in the ganglion cell layer of the retina (Fig 1B, E, H) . Immunolocalisation in the choroid was mild and inconsistent. The staining was similar in tissues of both sexes and its localisation was the same on frozen (not shown) and on paraYn sections. No staining could be observed in the absence of the primary antibody (Fig 1C, F, I ). Immunolocalisation of receptor antibody was more widespread in the neural retina (Fig 1A, D, G) and its localisation correlated with previously performed analysis on human tissue, with more intensity in the ganglion cell layer.
WESTERN BLOT ANALYSIS
The presence of oestrogen receptors and in the human retina was confirmed by western blot analysis with the appropriate antioestrogen receptor antibody (Fig 2) . Specimens contained a band of oestrogen receptor protein at a relative molecular mass of 67 kDa. The HT1080 cell line was used as a negative control in which no 67 kDa band was observed. A band was present in the testis (positive control).
OR mRNA EXPRESSION IN THE POSTERIOR SEGMENT
The primer specificity was checked using total RNA isolated from human testis and from endometrial Ishikawa cells and breast adenocarcinoma MCF-7 cells (data not shown). OR and OR primers amplified a 234 bp and a 258 bp fragment, respectively. OR and OR mRNA expression was detected in ocular tissues from patients of diVerent age and sex, regardless of the region of the sample (inside or outside the macula) (Fig 3) . The expression of OR mRNA was relatively constant between diVerent donors, while there was more variation with OR . This variation was also observed when RT-PCR was performed using total RNA selectively extracted from neural retina and the choroid region (Fig 4) . Both receptor subtypes mRNA were detected in the RPE-choroid complex, but OR was unequally distributed between the retina and the RPEchoroid (Fig 4) .
Discussion
In this report, we demonstrate the presence of OR in human male and female ocular posterior segment by immunohistochemistry, western blot analysis, and RT-PCR. At the transcriptional level, while the expression of OR was relatively constant, much more variability between diVerent specimens was observed for OR . This suggests the possibility of variation in the ratio of OR v OR mRNA expression. The precise eVects of oestrogens on the retina are largely unexplored and a detailed discussion about their potential action in retinal pathology is obviously speculative even if some epidemiological data suggest a protective eVect. Nevertheless, our results contribute to explain, at least partly, the beneficial eVects observed in retinal pathology with genistein treatment. Genistein is a naturally occurring phyto-oestrogen with a 20-fold aYnity diVerence for OR v OR . 15 Recent studies have focused on the role of phyto-oestrogens on angiogenesis and tumour development. 16 Genistein in vitro inhibits the proliferation of brain derived endothelial cells. 17 Oestradiol 17-is able to completely inhibit microvessels growth from explants of rat aorta embedded in collagen gel. 18 Genistein eVects described on retinal degeneration after ischaemia reperfusion in rat 19 or on experimental choroidal regeneration 20 were attributed to its inhibitory action on tyrosine kinases. Tyrosine kinase inhibition requires rather high local concentration of genistein (>10 µM) whereas a 0.1 µM concentration is suYcient to exert an OR mediated eVects. 21 In female rats receiving dietary genistein in high amounts (daily dose of 20 mg/kg of body weight), the concentration in serum was only 2.2 µM. 22 In a rat model of vascular endothelial injury associated with smooth muscle cell proliferation, a vasculoprotective eVect of genistein without eVect on the reproductive system was demonstrated by preferential targeting to OR . This observation was explained by the predominance of the OR subtype in the vascular wall, with a >40-fold upregulation of OR expression after injury, while OR expression remained unchanged. 23 Increasing experimental evidence demonstrate that oestrogens are neuroprotective 24 25 and that oestrogen replacement therapy may contribute to the prevention of, or even delay the onset of, Alzheimer's disease. 26 In the eye, macular degeneration has been associated with early menopause. 27 Precise biological mechanisms of oestrogen action on the retina still remain to be elucidated, but it is tempting to assume that one of the ways by which oestrogen could influence retinal biology is through RPE function. Relatively few genes are proved to be under the control of ORs. Among these is cathepsin D, an aspartic protease highly expressed in human retinal pigment epithelial lysosomes with transcription regulated by oestrogen. 28 Experimental impairment of cathepsin D results in accumulation of rod outer segment debris in the RPE. 29 Another possibility would be the systemic or local regulation of apolipoprotein E (Apo E) metabolism. Apo E and its alleles (apoE2, apoE3, apoE4) are believed to play a part in cardiovascular disease, 30 Alzheimer's disease, 31 and in AMD. 32 Mice on hypercholesterolic diet 33 or deficient for apoE 34 develop ultrastructural changes in Bruch's membrane similar to human basal linear deposits. Drusen, the hallmark of AMD, share some major components with atherosclerotic plaques, including among others apoE. 35 After brain injury, apoE is increased in areas of synaptic remodelling, and oestrogen increase apoE mRNA in astrocytes and microglia. 36 Importantly, it has been shown that oestrogen prevent atherosclerosis in apoE deficient male mice. 37 Finally, our observations suggest that under certain circumstances, the OR /OR expression ratio could vary in the eye. This provides a mechanism by which oestrogen could exert diVerent eVects on the same cell type. Indeed, it has recently been demonstrated in an experimental model using transient transfection that OR and OR , when complexed with oestrogen, were signalling in opposite ways (turning on/oV gene transcription) from an AP1 transcription site. 38 Additional experimental and epidemiological studies about the roles of oestrogens in normal and diseased retina are obviously mandatory. The demonstration of two diVerent receptor subtypes raises a perspective for preferential targeting.
